Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Evans Aldol Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108822072B details a high-yield diastereoselective Aldol route for Eliglustat intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN108484536B enables efficient orlistat intermediate production through a streamlined 7-step route that reduces costs and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN108484536B enables high-yield orlistat intermediate production with mild conditions, reducing costs and ensuring reliable pharmaceutical supply chains.